A Phase 1 Study of TT-00920 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 3, 2021

Primary Completion Date

June 6, 2022

Study Completion Date

June 6, 2022

Conditions

Healthy

Interventions

DRUG

TT-00920

Tablets

DRUG

TT-00920 Placebo

Tablets

Trial Locations (1)

The First Affiliated Hospital of Soochow University, Suzhou

All Listed Sponsors

lead

TransThera Sciences (Nanjing), Inc.

INDUSTRY

NCT05355129 - A Phase 1 Study of TT-00920 in Healthy Subjects | Biotech Hunter | Biotech Hunter